Download or read book Biotech Investing written by James D. Mccamant and published by Basic Books. This book was released on 2002-06-06 with total page 208 pages. Available in PDF, EPUB and Kindle. Book excerpt: Biotechnology is indisputably one of the fastest-growing and most promising industries. Virtually immune to swings in the economic cycles, biotech stocks continue to perform steadily as high-tech stocks lose their steam.In Biotech Investing, Jim McCamant offers proven strategies and savvy advice on how to capitalize on the unprecedented opportunities in this high-potential sector. Written by a recognized authority, this book dissects biotech business models from start-up to IPO and discusses in detail the most important factors that affect biotech research. Comprehensive in scope, it looks at the best and worst biotech contenders, discusses all the most newsworthy developments in the field, and shows how they translate into business success or failure. It outlines simple criteria for choosing the best biotech stocks and for understanding the sometimes complicated dynamics of this sector.
Download or read book The Biotech Investor s Bible written by George Wolff and published by John Wiley & Sons. This book was released on 2001-06-13 with total page 374 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The Biotech Investor's Bible" ist der maßgebliche Leitfaden für die Geldanlage in die zunehmend beliebteren, aber außerordentlich schwankungsanfälligen Biotechnologiewerte. Dieses einzigartige Buch erklärt die Grundlagen von Genetik, Patenten und Therapien und zeigt dem Anleger, wie er Biotechnologieunternehmen, deren Spitzentechnologie und neuesten Produkte bewertet. "The Biotech Investor's Bible" bietet eine interessante Zusammenfassung der relativ kurzen Geschichte dieses Industriezweiges und vermittelt einen umfassenden Überblick über verschiedene Branchenbereiche. Technologie und Wissenschaft des Biotechnologiemarktes werden zusammen mit detaillierten Investmentstrategien ausführlich erläutert. Autor George Wolff ist ein erfahrener Experte auf diesem Gebiet. "The Biotech Investor's Bible" ist eine unverzichtbare Lektüre für aktuelle und künftige Biotech-Anleger.
Download or read book The Biotech Investor written by Tom Abate and published by Times Books. This book was released on 2013-08-13 with total page 308 pages. Available in PDF, EPUB and Kindle. Book excerpt: A sophisticated investor's practical tool kit for analyzing the science, business, opportunities, and risks in the century's most promising industry The world is entering a biotechnology boom-but only informed investors will prosper in the incredibly complex biotech business. Separating the bioengineered wheat from the chaff, San Francisco Chronicle science and technology columnist Tom Abate, one of the top objective authorities on biotech, gives investors the analytical foundation to understand the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. In The Biotech Investor, Abate provides sophisticated business analysis, guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He explains how breaking news, medical conferences, U.S. Food and Drug Administration approvals, and the patent process affect investing strategies. Finally, he looks beyond medicine to review the financial opportunities presented by biotechnology advances in everything from agriculture to jean manufacturing, and shows investors how to identify "coattail" industries such as instrumentation and software development that will benefit from biotech successes. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
Download or read book The Biotech Investor s Bible written by George Wolff and published by John Wiley & Sons. This book was released on 2001-06-13 with total page 335 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The Biotech Investor's Bible" ist der maßgebliche Leitfaden für die Geldanlage in die zunehmend beliebteren, aber außerordentlich schwankungsanfälligen Biotechnologiewerte. Dieses einzigartige Buch erklärt die Grundlagen von Genetik, Patenten und Therapien und zeigt dem Anleger, wie er Biotechnologieunternehmen, deren Spitzentechnologie und neuesten Produkte bewertet. "The Biotech Investor's Bible" bietet eine interessante Zusammenfassung der relativ kurzen Geschichte dieses Industriezweiges und vermittelt einen umfassenden Überblick über verschiedene Branchenbereiche. Technologie und Wissenschaft des Biotechnologiemarktes werden zusammen mit detaillierten Investmentstrategien ausführlich erläutert. Autor George Wolff ist ein erfahrener Experte auf diesem Gebiet. "The Biotech Investor's Bible" ist eine unverzichtbare Lektüre für aktuelle und künftige Biotech-Anleger.
Download or read book Preserving the Promise written by Scott Dessain and published by Academic Press. This book was released on 2016-10-05 with total page 276 pages. Available in PDF, EPUB and Kindle. Book excerpt: Preserving the Promise: Improving the Culture of Biotech Investment critically examines why most biotech startups fail, as they emerge from universities into an ecosystem that inhibits rather than encourages innovation. This "Valley of Death" squanders our public investments in medical research and with them, the promise of longer and healthier lives. The authors explicate the Translation Gap faced by early stage biotech companies, the result of problematic technology transfer and investment practices, and provide specific prescriptions for improving translation of important discoveries into safe and effective therapies. In Preserving the Promise, Dessain and Fishman build on their collective experience as company founders, healthcare investor (Fishman) and physician/scientist (Dessain). The book offers a forward-looking, critical analysis of "conventional wisdom" that encumbers commercialization practices. It exposes the self-defeating habits of drug development in the Valley of Death, that waste money and extinguish innovative technologies through distorted financial incentives. Explains why translation of biotech discovery into medicine succeeds so infrequently that it’s been dubbed the Valley of Death Uncovers specific decision-making strategies that more effectively align incentives, improving clinical and financial outcomes for investors, inventor/entrepreneurs, and patients Examines the critical, early stages of commercialization, where technology transfer offices and Angels act as gatekeepers to development, and where tension between short-term financial and long-term clinical aspirations sinks important technologies Deconstructs the forces driving biotech, recasts them in a proven conceptual framework, and offers practical guidance for making the system better
Download or read book Successful Biotech Investing written by Joe Duarte and published by Prima Lifestyles. This book was released on 2001 with total page 424 pages. Available in PDF, EPUB and Kindle. Book excerpt: Medical biotechnology is a multibillion dollar global industry, and is growing rapidly. Breakout companies worldwide present highly profitable investment opportunities, but many investors avoid the sector because the science is difficult to understand and the opportunities easy to miss. Where can the layperson find reliable, fundamental information about biotechnology in order to make informed investment decisions?In Successful Biotech Investing, market expert and physician Joe Duarte, M.D., makes investing in biotech companies -- and understanding the basic science -- easy. He combines his professional medical insight and extensive financial experience to help investors easily master how to: * Interpret the science to make informed investment decisions* Analyze biotech companies for research, patents, and growth potential* Pick biotech mutual funds and indexes for maximum profit* Identify related opportunities in pharmaceutical and health-care companies* Understand the impact of the FDA and international regulations* And much moreWritten for smart investors who want to learn more about biotech and its opportun
Download or read book The Essential Biotech Investment Guide written by Chilung Mark Tang and published by World Scientific. This book was released on 2002 with total page 294 pages. Available in PDF, EPUB and Kindle. Book excerpt: This invaluable book tells the reader how to invest in the healthcare biotechnology and life sciences sector, one of the fast-growing sectors of the US economy. Aimed at biotech investors as well as bioentrepreneurs and venture capitalists, it has been written from the perspectives of risk management and asset management/allocation. It strives to teach readers how to fish, rather than giving them fish. The author has over ten years of Wall Street experience in biotech research, investment banking and asset management. He holds an MBA in Finance and a PhD in Biochemistry.
Download or read book Biotechnology Entrepreneurship written by Craig Shimasaki and published by Academic Press. This book was released on 2014-04-08 with total page 489 pages. Available in PDF, EPUB and Kindle. Book excerpt: As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts
Download or read book Biotechnology Valuation written by Karl Keegan and published by John Wiley & Sons. This book was released on 2008-12-31 with total page 228 pages. Available in PDF, EPUB and Kindle. Book excerpt: The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company
Download or read book From Breakthrough to Blockbuster written by Donald L. Drakeman and published by Oxford University Press. This book was released on 2022 with total page 241 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Download or read book Investing in Biotechnology Stocks written by Leo Gough and published by John Wiley & Sons. This book was released on 2001-08-28 with total page 268 pages. Available in PDF, EPUB and Kindle. Book excerpt: Leading investment author and journalist Leo Gough provides them with a rare insider's look at the biotech industries based on extensive interviews with industry analysts, CEOs, and leading scientists at top biotech firms, including Merck & Co., Eli Lilly & Co., Amgen Ltd., SmithKline Beecham, Inc., Genzyme Corp., Monsanto, and others."--BOOK JACKET.
Download or read book Healthcare Investing Profiting from the New World of Pharma Biotech and Health Care Services written by Les Funtleyder and published by McGraw Hill Professional. This book was released on 2008-12-31 with total page 289 pages. Available in PDF, EPUB and Kindle. Book excerpt: Is your portfolio in peak health? Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for investment gain.” Health-Care Investing provides a thorough explanation of how the industry's mammoth size and complexity can be worked to your advantage and why health care is more resistant to changes in economic cycles than other markets. Funtleyder gives you a comprehensive overview of the industry, from both macro and micro points of view, so you can make informed decisions regarding your investments. You'll find critical information concerning The natural inelasticity of health care and how to profit from it How to take advantage of the market's complexities and inefficiencies Issues and policy changes you need to know The social responsibility aspect of investing in health care Why this market is essential for diversified portfolios In Health-Care Investing, Funtleyder provides the tools you need to dig up the richest opportunities possible and build them into your investment strategy. You'll get a detailed look at traditional market patterns and the events that have shaped--and will continue to shape--the industry. Then you'll find specific strategies you can use to maximize your profits, whether you invest in pharma, biotech, managed services, or a combination of them. This informative and practical guide also includes a list of questions you can use as an investment “template,” which will help guide your decision-making process. With Health Care Investing, you'll be armed with the know-how to make the right decisions today in order to fully capitalize on events of the future.
Download or read book Cracking the Code written by Jim Mellon and published by John Wiley & Sons. This book was released on 2012-04-20 with total page 363 pages. Available in PDF, EPUB and Kindle. Book excerpt: Everything you need to know about the most important trend in the history of the world Within most people's lifetimes, the developments in the biotechnology sector will allow us to live increasingly long and healthy lives, as well as provide us with technological innovations that will transform the way we live. But these innovations offer more than just hope for a better life, but hope for better returns too. Financial returns of incredible magnitude await savvy investors and businesspeople who can see the massive changes on the horizon. This book details these fast-moving trends and innovations and offers extensive advice on how to profit from them in business and investing.
Download or read book Building Biotechnology written by Yali Friedman and published by Thinkbiotech. This book was released on 2006 with total page 306 pages. Available in PDF, EPUB and Kindle. Book excerpt: Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry: * Cultivate a career in biotechnology, with or without an MBA or Ph.D. * Fund and assemble a company * Manage research and development, alliances, and funding * Understand the diverse factors defining the biotechnology industry * Invest intelligently in biotechnology This second edition significantly expands upon the foundation laid by the first, updating recent developments and adding significantly more case studies, informative figures and tables.
Download or read book Investing in Biotech written by David G. Harper and published by Raincoast Books. This book was released on 2002 with total page 268 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Helps you understand one of the most discussed but least understood sectors of the knowledge economy." - preface.
Download or read book Venture Capital and the European Biotechnology Industry written by W. Bains and published by Springer. This book was released on 2008-11-20 with total page 220 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book opens up the world on private equity investment in one of the hottest industries – Biotechnology. The book describes how Europe has fallen behind the US due to under-investment and bad management by the VCs who control the companies. Detailed analysis shows why it is in VCs' interests to damage the very companies they invest in.
Download or read book Science Business written by Gary P. Pisano and published by Harvard Business Press. This book was released on 2006 with total page 278 pages. Available in PDF, EPUB and Kindle. Book excerpt: Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.
